LENZ Therapeutics, Inc. (LENZ)
5.22
+0.01
(+0.19%)
USD |
NASDAQ |
Sep 01, 16:00
5.22
0.00 (0.00%)
After-Hours: 20:00
LENZ Therapeutics Cash from Operations (TTM) : -113.91M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -113.91M |
| March 31, 2026 | -86.70M |
| December 31, 2025 | -69.17M |
| September 30, 2025 | -45.22M |
| June 30, 2025 | -47.22M |
| March 31, 2025 | -51.50M |
| December 31, 2024 | -59.39M |
| September 30, 2024 | -71.28M |
| June 30, 2024 | -73.79M |
| March 31, 2024 | -71.52M |
| December 31, 2023 | -60.38M |
| September 30, 2023 | -61.84M |
| Date | Value |
|---|---|
| June 30, 2023 | -70.97M |
| March 31, 2023 | -79.54M |
| December 31, 2022 | -87.98M |
| September 30, 2022 | -81.14M |
| June 30, 2022 | -74.34M |
| March 31, 2022 | -66.03M |
| December 31, 2021 | -52.85M |
| September 30, 2021 | -42.53M |
| June 30, 2021 | -29.61M |
| March 31, 2021 | -16.78M |
| December 31, 2020 | -8.721M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ocular Therapeutix, Inc. | -238.24M |
| Enveric Biosciences, Inc. | -8.561M |
| Liquidia Corp. | 167.71M |
| Aquestive Therapeutics, Inc. | -45.36M |
| Impact BioMedical, Inc. | -0.508M |